Structures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation

Cell

Volumn 112, Issue 1, 2003, Pages 99-111

  Shimaoka, Motomu ^e   Xiao, Tsan ^e   Liu, Jin Huan ^a   Yang, Yuting ^a   Dong, Yicheng ^a,c   Jun, Chang Duk ^d   McCormack, Alison ^e   Zhang, Rongguang ^b   Joachimiak, Andrzej ^b   Takagi, Junichi ^e   Wang, Jia Huai ^a   Springer, Timothy A ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d Wonkwang University   (South Korea)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAGNESIUM ION; PROTEIN SUBUNIT;

ALLOSTERISM; ALPHA CHAIN; ALPHA HELIX; BETA CHAIN; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DIMERIZATION; DISULFIDE BOND; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

EID: 0037428080     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)01257-6     Document Type: Article

References (59)

1. Alonso J.L., Essafi M., Xiong J.P., Stehle T., Arnaout M.A. Does the integrin αA domain act as a ligand for its βA domain? Curr. Biol. 12:2002;R340-R342.
2. Bella J., Kolatkar P.R., Marlor C., Greve J.M., Rossmann M.G. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand. Proc. Natl. Acad. Sci. USA. 95:1998;4140-4145.
3. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N.S.et al. Crystallography & NMR system. a new software suite for macromolecular structure determination Acta Crystallogr. D. 54:1998;905-921.
4. Casasnovas J.M., Springer T.A., Liu J.-h., Harrison S.C., Wang J.-h. The crystal structure of ICAM-2 reveals a distinctive integrin recognition surface. Nature. 387:1997;312-315.
5. Casasnovas J.M., Stehle T., Liu J.-h., Wang J.-h., Springer T.A. A dimeric crystal structure for the N-terminal two domains of ICAM-1. Proc. Natl. Acad. Sci. USA. 95:1998;4134-4139.
6. 2+ or antibody activation J. Biol. Chem. 276:2001;48670-48678.
7. Constantin G., Majeed M., Giagulli C., Piccib L., Kim J.Y., Butcher E.C., Laudanna C. Chemokines trigger immediate β2 integrin affinity and mobility changes. differential regulation and roles in lymphocyte arrest under flow Immunity. 13:2000;759-769.
8. Conte L.L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285:1999;2177-2198.
9. Diamond M.S., Springer T.A. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J. Cell Biol. 120:1993;545-556.
10. Dustin M.L., Springer T.A. T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature. 341:1989;619-624.
11. Dustin M.L., Springer T.A. Intercellular adhesion molecules (ICAMs). Kreis T., Vale R. Guidebook to the Extracellular Matrix and Adhesion Proteins. 1999;Sambrook and Tooze, New York.
12. Dustin M.L., Carpen O., Springer T.A. Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. J. Immunol. 148:1992;2654-2663.
13. Edwards C.P., Fisher K.L., Presta L.G., Bodary S.C. Mapping the intercellular adhesion molecule-1 and -2 binding site on the inserted domain of leukocyte function-associated antigen-1. J. Biol. Chem. 273:1998;28937-28944.
14. Emsley J., King S.L., Bergelson J.M., Liddington R.C. Crystal structure of the I domain from integrin α2β1. J. Biol. Chem. 272:1997;28512-28517.
15. Emsley J., Knight C.G., Farndale R.W., Barnes M.J., Liddington R.C. Structural basis of collagen recognition by integrin α2β1. Cell. 101:2000;47-56.
16. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15:1997;132-138.
17. Fisher K.L., Lu J., Riddle L., Kim K.J., Presta L.G., Bodary S.C. Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1. Mol. Biol. Cell. 8:1997;501-515.
18. 2-integrins and their cellular ligands Eur. J. Biochem. 245:1997;215-232.
19. Giancotti F.G., Ruoslahti E. Integrin signaling. Science. 285:1999;1028-1032.
20. Giblin P.A., Kelly T.A. Antagonists of β2 integrin-mediated cell adhesion. Annu. Rep. Med. Chem. 36:2001;181-190.
21. Gottlieb A., Krueger J.G., Bright R., Ling M., Lebwohl M., Kang S., Feldman S., Spellman M., Wittkowski K., Ochs H.D.et al. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J. Am. Acad. Dermatol. 42:2000;428-435.
22. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse. a molecular machine controlling T cell activation Science. 285:1999;221-227.
23. Hodel A., Kim S.-H., Brünger A.T. Model bias in macromolecular crystal structures. Acta Crystallogr. A48:1992;851-858.
24. Huang C., Springer T.A. A binding interface on the I domain of lymphocyte function associated antigen-1 (LFA-1) required for specific interaction with intercellular adhesion molecule 1 (ICAM-1). J. Biol. Chem. 270:1995;19008-19016.
25. Hughes P.E., Pfaff M. Integrin affinity modulation. Trends Cell Biol. 8:1998;359-364.
26. Huth J.R., Olejniczak E.T., Mendoza R., Liang H., Harris E.A., Lupher M.L. Jr., Wilson A.E., Fesik S.W., Staunton D.E. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc. Natl. Acad. Sci. USA. 97:2000;5231-5236.
27. Jones T.A., Kjeldgaard M. O Version 5.9. 1993;Uppsala University, Uppsala, Sweden.
28. Kallen J., Welzenbach K., Ramage P., Geyl D., Kriwacki R., Legge G., Cottens S., Weitz-Schmidt G., Hommel U. Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. J. Mol. Biol. 292:1999;1-9.
29. Kamata T., Wright R., Takada Y. Critical threonine and aspartic acid residues within the I domains of β2 integrins for interactions with intercellular adhesion molecule 1 (ICAM-1) and C3bi. J. Biol. Chem. 270:1995;12531-12535.
30. Koopman G., Keehnen R.M.J., Lindhout E., Newman W., Shimizu Y., Van Seventer G.A., deGroot C., Pals S.T. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J. Immunol. 152:1994;3760-3767.
31. Kraulis P. Molscript. a program to produce both detailed and schematic plots of protein structure J. Appl. Crystallogr. 24:1991;946-950.
32. Larson R.S., Springer T.A. Structure and function of leukocyte integrins. Immunol. Rev. 114:1990;181-217.
33. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck. a program to check the stereochemical quality of protein structures J. Appl. Crystallogr. 26:1993;283-291.
34. Lee J.-O., Bankston L.A., Arnaout M.A., Liddington R.C. Two conformations of the integrin A-domain (I-domain). a pathway for activation? Structure. 3:1995;1333-1340. a.
35. Lee J.-O., Rieu P., Arnaout M.A., Liddington R. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell. 80:1995;631-638. b.
36. Legge G.B., Kriwacki R.W., Chung J., Hommel U., Ramage P., Case D.A., Dyson H.J., Wright P.E. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1. J. Mol. Biol. 295:2000;1251-1264.
37. Li R., Haruta I., Rieu P., Sugimori T., Xiong J.P., Arnaout M.A. Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b. J. Immunol. 168:2002;1219-1225.
38. Lollo B.A., Chan K.W.H., Hanson E.M., Moy V.T., Brian A.A. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J. Biol. Chem. 268:1993;21693-21700.
39. Lu C., Shimaoka M., Zang Q., Takagi J., Springer T.A. Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc. Natl. Acad. Sci. USA. 98:2001;2393-2398.
40. Lupher M.L. Jr., Harris E.A., Beals C.R., Sui L., Liddington R.C., Staunton D.E. Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site. J. Immunol. 167:2001;1431-1439.
41. Ma Q., Shimaoka M., Lu C., Jing H., Carman C.V., Springer T.A. Activation induced conformational changes in the I domain region of LFA-1. J. Biol. Chem. 277:2002;10638-10641.
42. Merritt E.A., Murphy M.E.P. Raster 3D version 2.0. a program for photorealistic graphics Acta Crystallogr. D50:1994;869-873.
43. Navaza J. Amore. an automated package for molecular replacement Acta Crystallogr. A50:1994;157-163.
44. Nicholls A., Sharp K.A., Honig B. Protein folding and association; insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-296.
45. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
46. Oxvig C., Lu C., Springer T.A. Conformational changes in tertiary structure near the ligand binding site of an integrin I domain. Proc. Natl. Acad. Sci. USA. 96:1999;2215-2220.
47. Perrakis A., Harkiolaki M., Wilson K.S., Lamzin V.S. ARP/warp and molecular replacement. Acta Crystallogr. D. 57:2001;1445-1450.
48. Lβ2) integrin. Proc. Natl. Acad. Sci. USA. 92:1995;10277-10281.
49. Qu A., Leahy D.J. The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure. 4:1996;931-942.
50. Schwartz M.A., Ginsberg M.H. Networks and crosstalk. integrin signalling spreads Nat. Cell Biol. 4:2002;E65-E68.
51. Sheldrick G.M., Schneider T.R. Shelxl. high resolution refinement Sweet R.M., Carter C.W. Jr. Methods in Enzymology. 1997;Academic Press, Orlando, FL. 319-343.pp.
52. Shimaoka M., Lu C., Palframan R., von Andrian U.H., Takagi J., Springer T.A. Reversibly locking a protein fold in an active conformation with a disulfide bond. integrin α L I domains with high affinity and antagonist activity in vivo Proc. Natl. Acad. Sci. USA. 98:2001;6009-6014.
53. Shimaoka M., Takagi J., Springer T.A. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:2002;485-516.
54. Staunton D.E., Dustin M.L., Erickson H.P., Springer T.A. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell. 61:1990;243-254.
55. Stewart M.P., Cabanas C., Hogg N. T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1. J. Immunol. 156:1996;1810-1817.
56. Takagi J., Petre B.M., Walz T., Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 110:2002;599-611.
57. van Kooyk Y., van Vliet S.J., Figdor C.G. The actin cytoskeleton regulates LFA-1 ligand binding through avidity rather than affinity changes. J. Biol. Chem. 274:1999;26869-26877.
58. Van Seventer G.A., Shimizu Y., Horgan K.J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:1990;4579-4586.
59. Wang J.-h., Springer T.A. Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunol. Rev. 163:1998;197-215.